September 6 2019
A structured guide to antitrust law in the pharmaceutical sector in Norway, including the legislative and regulatory framework, merger review, anticompetitive agreements and abuse of dominance.
June 21 2022
A look at key practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in Norway, including IP rights abuse and pricing conduct.
June 21 2022
The essential legal considerations surrounding anticompetitive agreements in the pharmaceutical sector in Norway, including the assessment framework and special issues with vertical agreements.
June 21 2022
This article looks at some of the key legal and practical issues surrounding the competition authorities' review of mergers in the pharmaceutical sector in Norway, including review triggers and thresholds.